Status:
UNKNOWN
Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Androgenetic Alopecia
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
Microneedling and autologous concentrated growth factor (CGF) have established their potential effect in inducing hair regrowth. No study has compared the effect of microneedling and CGF in the treatm...
Detailed Description
Microneedling is a minimally invasive technique consisting of sterile microneedles for repetitive cutaneous puncturing that increase hair regrowth by growth factor release. Concentrated growth factor ...
Eligibility Criteria
Inclusion
- age between 18 and 65 years;；
- clinical diagnosis of female pattern hair loss；
- no previous laser treatments for AGA in the past six months before enrollment； 4) willingness to provide pictures and follow-up studies.
Exclusion
- if presented with severe diseases of internal organs, eyes, or skin;
- inflammation, infection, or unhealed wounds on the skin around the site of treatment on the head;
- systematic treatment with corticosteroids or other immunosuppressants and immunomodulators in the past 3 months.
Key Trial Info
Start Date :
December 14 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT06218394
Start Date
December 14 2023
End Date
December 31 2024
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Second Affiliated Hospital, School of Medicine, Zhejiang University, China
Hangzhou, Zhejiang, China, 310009